Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-27

Clinical Trial Update: Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study assessing the absolute bioavailability, safety, and tolerability of subcutaneous GS-5745 in healthy adults. Ulcerative Colitis is listed as a tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GS-5745

Snippet

Sponsor: Gilead Sciences | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED